SCHEMBL6007229

SCHEMBL6007229

Cc1ccc(S(=O)(=O)NC(CCN2CCC(Cc3ccccc3)CC2)c2ccccc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.56
MAPK1 P28482 1/20 0.56
ATM Q13315 1/20 0.56
MEN1 O00255 1/20 0.54
HTT P42858 1/20 0.54
KMT2A Q03164 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
TMEM97 Q5BJF2 1/20 0.48
SLC6A2 P23975 2/20 0.48
SLC6A3 Q01959 2/20 0.48
CCR5 P51681 2/20 0.48
GRIN2D O15399 1/20 0.47
GRIN3B O60391 1/20 0.47
ADRA1D P25100 1/20 0.47
ADRA1A P35348 1/20 0.47
ADRA1B P35368 1/20 0.47
GRIN1 Q05586 1/20 0.47
GRIN2A Q12879 1/20 0.47
GRIN2B Q13224 1/20 0.47
GRIN2C Q14957 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5448769 0.93 SLC6A2 (0.53) KDM4EMEN1KMT2ASLC6A2SLC6A3
SCHEMBL6008053 0.85 SLC6A2 (0.54) MEN1KMT2ASLC6A2SLC6A3CCR5
SCHEMBL6007256 0.82 MEN1 (0.56) MEN1KMT2ASLC6A2SLC6A3CCR5
SCHEMBL28856634 0.82 ALDH1A1 (0.57) KDM4EMAPK1MEN1KMT2ASMN1; SMN2
SCHEMBL6007222 0.81 ALDH1A1 (0.56) MAPK1MEN1KMT2ASLC6A2SLC6A3
SCHEMBL6009357 0.81 TMEM97 (0.47) MEN1HTTKMT2ATMEM97SLC6A2
SCHEMBL6008682 0.81 OPRM1 (0.46) SLC6A2SLC6A3CCR5GRIN2DGRIN3B
SCHEMBL5458579 0.79 CCR5 (0.48) KDM4EKMT2ACCR5ADRA1DADRA1A
SCHEMBL6008830 0.79 PRMT6 (0.63) MEN1KMT2ASLC6A2SLC6A3GRIN2D
SCHEMBL5453901 0.78 KMT2A (0.41) MAPK1MEN1KMT2ACCR5OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078537-B2 Phenylalkyl diamine and amide analogs SK CORPORATION (KR) 2006-07-18 US claimed
US-7078537-B2 Phenylalkyl diamine and amide analogs SK CORPORATION (KR) 2006-07-18 US disclosed
US-20030105079-A1 Novel phenylalkyl diamine and amide analogs SK BIOPHARMACEUTICALS CO., LTD. (KR) 2003-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105079-A1 Novel phenylalkyl diamine and amide analogs SIGMAR1, TAAR1, OPRL1 KDM4E 2001/4885MAPK1 1120/4885ATM 3190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.